Merck &, Co has announced that ... in patients with type 2 diabetes who had inadequate glycemic control on diet and excercise. A total of 685 patients with a mean baseline HbA1c of ...
low-carbohydrate diet delays the need for antihyperglycemic drug therapy in overweight patients with type 2 diabetes mellitus (T2DM). The randomized trial also shows that the Mediterranean diet ...
Merck and Pfizer are to take ... as a monotherapy in conjunction with diet and exercise to improve glycaemic control in adults with type 2 diabetes. Meanwhile Steglujan (ertugliflozin+sitagliptin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback